Funding for this research was provided by:
European Social Fund (09.3.3-LMT-K-712-01-0041)
Received: 28 April 2020
Accepted: 14 September 2020
First Online: 20 October 2020
Ethics approval and consent to participate
: The study was approved by the Research Ethics Committee of the University of Tartu (246/T-21 and 213/T-21) and written informed consent was obtained from all participants.
: Not applicable.
: E.K., J.G., M.N. and P.G. are authors of a patent application related to NIPT based on TOP-seq strategies.